Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Koselugoinhibits tumor cell proliferation by inhibiting MEK protein activity, bl···【more】
Release date：2024-08-23Recommended：257
Koselugo is a targeted therapy drug primarily used to treat a specific subtype o···【more】
Release date：2024-08-23Recommended：286
Alpelisib is a drug for the treatment of HR/HER2- breast cancer, especially for ···【more】
Release date：2024-08-22Recommended：256
Alpelisib for the treatment of PIK3CA-mutated HR/HER2- advanced breast cancer in···【more】
Release date：2024-08-22Recommended：247
Alpelisib, approved in combination with fulvestrant in 2019 for the treatment of···【more】
Release date：2024-08-22Recommended：272
Anamorelin is a ghrelin receptor agonist used to treat cancer cachexia and signi···【more】
Release date：2024-08-22Recommended：223
Anamorelin is currently the only effective therapeutic drug that promotes appeti···【more】
Release date：2024-08-22Recommended：219
Koselugois a precision small molecule MEK blocker engineered for specific tumors···【more】
Release date：2024-08-22Recommended：255
Anamorelin is a ghrelin receptor agonist launched in Japan that brings a new tre···【more】
Release date：2024-08-22Recommended：247
Koselugois a precision small molecule MEK inhibitor designed for specific tumor ···【more】
Release date：2024-08-22Recommended：318
Koselugo is a carefully developed small molecule MEK blocker (also known as a mi···【more】
Release date：2024-08-22Recommended：307
As the world's first drug specifically for the treatment of cachexia, Anamor···【more】
Release date：2024-08-22Recommended：213
